CURRENT PARTNERSHIP
Our business model, expertise, and diverse team have made us a partner of choice for research institutes and biotechnology companies working on lung diseases.
PARTNERING
Oncofibro is a portfolio company of Actus Lux, an entrepreneurial single-family office of a seasoned biotech investor. Actus Lux works with sophisticated capital via Singapore Bio Angels (SGBA) as well as being a Limited Partner [LP] /General Partner (GP) stake as Fund of Funds in a Monetary Authority of Singapore (MAS) licensed fund management company Allied Impact Capital. This meets the shared goal of enabling humans to actualize and achieve their self-potential before we meet our creator.
